España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Adicet Bio
ACET
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.9389
0.03
3.36%
At close: -
$0.9364
-0.00250
-0.27%
After Hours: 6:06 PM EDT
Get Report
Comment
Adicet Bio (ACET) Forecast
News
Earnings
Adicet Bio (ACET) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Adicet Bio (NASDAQ:ACET) Stock
Adicet Bio Stock (NASDAQ: ACET)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 08, 2025
Adicet Bio Highlights Key 2025 Milestones Fol...
Benzinga Newsdesk
Thursday, December 19, 2024
HC Wainwright & Co. Reiterates Neutral on Adi...
Benzinga Newsdesk
Adicet Bio Says First Patient Dosed In The Ph...
Benzinga Newsdesk
Monday, November 18, 2024
Adicet Opens Enrollment For ADI-270 Phase 1 C...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Neutral on Adi...
Benzinga Newsdesk
Reported Saturday, Adicet Bio Shared Clinical...
Benzinga Newsdesk
Wednesday, November 06, 2024
Adicet Bio Q3 EPS $(0.34) Beats $(0.35) Estim...
Benzinga Newsdesk
Wednesday, October 16, 2024
HC Wainwright & Co. Reiterates Neutral on Adi...
Benzinga Newsdesk
Adicet Bio shares are trading higher after th...
Benzinga Newsdesk
Adicet Bio Announces FDA Clearance Of An IND ...
Benzinga Newsdesk
Monday, September 30, 2024
HC Wainwright & Co. Reiterates Neutral on Adi...
Benzinga Newsdesk
Friday, September 20, 2024
Wedbush Reiterates Outperform on Adicet Bio, ...
Benzinga Newsdesk
Thursday, September 19, 2024
HC Wainwright & Co. Reiterates Neutral on Adi...
Benzinga Newsdesk
Adicet Bio Announced ADI-001 Clinical Biomark...
Benzinga Newsdesk
Wednesday, September 11, 2024
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
Avi Kapoor
Jones Trading Maintains Buy on Adicet Bio, Lo...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Adicet Bio...
Benzinga Newsdesk
HC Wainwright & Co. Downgrades Adicet Bio to ...
Benzinga Newsdesk
Tuesday, September 10, 2024
Adicet Bio Shifts Focus to Autoimmune Disease...
Benzinga Newsdesk
Wednesday, August 14, 2024
HC Wainwright & Co. Reiterates Buy on Adicet ...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Adicet Bio...
Benzinga Newsdesk
Tuesday, August 13, 2024
Adicet Bio Q2 2024 GAAP EPS $(0.33) Beats $(0...
Benzinga Newsdesk
Monday, July 08, 2024
HC Wainwright & Co. Reiterates Buy on Adicet ...
Benzinga Newsdesk
Adicet Bio shares are trading higher after th...
Benzinga Newsdesk
The FDA Has Granted Fast Track Designation To...
Benzinga Newsdesk
Monday, June 24, 2024
HC Wainwright & Co. Reiterates Buy on Adicet ...
Benzinga Newsdesk
Adicet Bio Announces FDA Clearance Of Its IND...
Benzinga Newsdesk
Wednesday, June 05, 2024
HC Wainwright & Co. Reiterates Buy on Adicet ...
Benzinga Newsdesk
Adicet Bio shares are trading higher after th...
Benzinga Newsdesk
Adicet Bio Says FDA Has Granted Fast Track De...
Benzinga Newsdesk
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Adicet ...
Benzinga Newsdesk
Tuesday, May 14, 2024
Adicet Bio Q1 2024 Adj EPS $(0.35) Beats $(0....
Benzinga Newsdesk
Adicet Bio Announces Poster Presentation Of A...
Benzinga Newsdesk
Tuesday, April 23, 2024
Wedbush Reiterates Outperform on Adicet Bio, ...
Benzinga Newsdesk
Monday, April 22, 2024
Adicet Today Presented Abstract Featuring Pre...
Benzinga Newsdesk
Tuesday, April 02, 2024
HC Wainwright & Co. Maintains Buy on Adicet B...
Benzinga Newsdesk
Friday, March 22, 2024
Adicet Bio May Offer And Sell Shares Of Commo...
Benzinga Newsdesk
Wednesday, March 20, 2024
HC Wainwright & Co. Reiterates Buy on Adicet ...
Benzinga Newsdesk
Wedbush Reiterates Outperform on Adicet Bio, ...
Benzinga Newsdesk
Canaccord Genuity Reiterates Buy on Adicet Bi...
Benzinga Newsdesk
Tuesday, March 19, 2024
Adicet Bio: Q4 Earnings Insights
Benzinga Insights
Adicet Bio Q4 2023 GAAP EPS $(0.69) Beats $(0...
Benzinga Newsdesk
Friday, February 02, 2024
HC Wainwright & Co. Maintains Buy on Adicet B...
Benzinga Newsdesk
Tuesday, January 23, 2024
Adicet Bio Prices Public Offering Of 27,054,6...
Benzinga Newsdesk
Monday, January 22, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Adicet Bio, Inc. Announces Proposed Public Of...
Benzinga Newsdesk
IN8bio's Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data
Faith Ashmore
-
Sponsored
Tuesday, January 09, 2024
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Friday, January 05, 2024
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Chris Katje
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
